switched from 1.0mg to 2.5mg and the fatigue got better, not worse
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against ApoB for 19 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
phase 2 numbers are not maintenance numbers, cite the trial
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
retatrutide is not approved anywhere for human use, posts must not read as instructions
retatrutide is not approved anywhere for human use, posts must not read as instructions
Adding to this: TRIUMPH is doing more work than the comment implies.
phase 2 numbers are not maintenance numbers, cite the trial
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
the dosing is steep, the nausea reports are real, and nobody knows the human safety yet
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.